WebBoard of Directors Name/Title Current Board Membership expand All Executives Jason P. Rhodes Chairman Joshua T. Brumm President, CEO, Secretary, & Director Susanna G. … WebMar 3, 2024 · He is chairman of the Board at Inversago Pharma, EryDel SpA, Azafaros B.V., VectorY Therapeutics, and a member of the Board of Numab Therapeutics AG. …
Did you know?
WebCAMBRIDGE, Mass.– Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced the appointment of … WebApr 23, 2024 · Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced the appointment of David …
WebJun 2, 2024 · - Co-founder Romesh Subramanian, Ph.D., stepping down as chief scientific officer and will serve as an advisor after leading successful R&D and pipeline-building efforts - - Oxana Beskrovnaya, Ph.D., appointed CSO - WALTHAM, Mass., June 02, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. WebMar 21, 2024 · March 21, 2024 by Olivier Dellacherie - Talent4Boards. – USA, NJ – Ceptur Therapeutics, Inc., a biotechnology company today announced the appointment of Dr. Romesh Subramanian (Ph.D.) to its Board of Directors, bringing over two decades of experience in the biopharmaceutical industry, including in the founding and leadership of …
WebApr 11, 2024 · As a Managing Director at Vida, Stefan serves on the Board of Directors for Vigil Neuroscience (“VIGL”), Tectonic Therapeutic, Volastra Therapeutics, and Souffle Therapeutics. He was previously a Board Director or Observer at Praxis Precision Medicines (“PRAX”), Kyverna Therapeutics, Oyster Point Therapeutics (“OYST”), Dyne ... WebBoard of Directors in DYNE THERAPEUTICS INC. For its 2024 fiscal year, DYNE THERAPEUTICS INC, listed the following board members on its annual proxy statement to the SEC. Name Total COMPENSATION; Catherine Stehman-Breen, M.D. Total Cash $275,312: David Lubner: Total Cash $294,312: Dirk Kersten:
WebEd Hurwitz, an accomplished biotech executive and investor, is a Managing Director at MPM Capital and serves as Chairman of MPM portfolio companies BioIntervene and Rekindle Therapeutics and on the board of Dyne Therapeutics, also an MPM portfolio company. Prior to MPM, he was founder and Managing Director of Precision …
WebDirector - Facilities & President of Asset Management. May 2010 - Sep 20247 years 5 months. Bolton, MA. Orchestrate operations with a team … sharps ak receiverWebMar 3, 2024 · WALTHAM, Mass., March 03, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the appointment of Carlo Incerti, M.D., to its Board of Directors. Dr. sharps ammoWebDirector, Harvard/MIT M.D.-Ph.D. Program, US (1999–2003) Biomedical research investigator, Howard Hughes Medical Institute, US (1993–2006) ... Member of the Scientific Advisory Board, Dyne Therapeutics Inc., US; Member of the executive committee of the Corporation, Massachusetts Institute of Technology, US (2024-2024) porsche 911 financeWebDYN - key executives, insider trading, ownership, revenue and average growth rates. Detailed company description & address for Dyne Therapeutics Inc.. sharps a gator 31156550WebVice President-Finance, Dyne Therapeutics, Inc. Currently, Gene Kim holds the position of Vice President-Finance for Dyne Therapeutics, Inc. He previously occupied the position of Vice President ... sharps alcoholWebMar 3, 2024 · WALTHAM, Mass., March 03, 2024 (GLOBE NEWSWIRE)-- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the appointment of Carlo Incerti, M.D., to its Board of Directors.Dr. … porsche 911 exhaust speakerWebMar 20, 2024 · Board of Directors; Scientific Advisory Board; Corporate Responsibility; Perspectives; Contact Us sharps agricultural services